Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (551-560 of 799) with videos related to

Pageof 80
Sort By:
Geburtshilfe Und Frauenheilkunde|January 29, 2019
Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility PreservationMatthias W Beckmann, Laura Lotz, Bettina Toth, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
BMC Cancer|November 12, 2020
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in GermanyHanna Huebner, Christian M Kurbacher, Geoffrey Kuesters, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
Pageof 80

Showing results (551-560 of 799) with videos related to

Sort By:
Pageof 80
Geburtshilfe Und Frauenheilkunde|January 29, 2019
Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility PreservationMatthias W Beckmann, Laura Lotz, Bettina Toth, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
BMC Cancer|November 12, 2020
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in GermanyHanna Huebner, Christian M Kurbacher, Geoffrey Kuesters, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
Pageof 80